Alzheimer's disease vaccine - Elan/Wyeth
Latest Information Update: 15 Feb 2008
At a glance
- Originator Tel Aviv University
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 19 Dec 2005 No development reported - Preclinical for Alzheimer's disease in Israel (unspecified route)
- 26 Mar 2002 American Home Products has changed its name and the names of its subsidiaries Wyeth-Ayerst and Wyeth-Lederle to Wyeth
- 09 Jul 2001 Elan and American Home Products have licensed the vaccine